BIOMILQ

BIOMILQ is a biotechnology company that develops lab-grown breast milk for babies using patent-pending technology. The company aims to provide families with a nutritionally complete alternative to traditional infant formula by culturing mammary cells to produce milk components that closely resemble human breast milk. This approach addresses the limitations of conventional formula by offering a product that more closely matches the nutritional and bioactive profile of breast milk. Founded in 2020 and headquartered in Durham, United States, BIOMILQ has raised $24.5M in Series A funding from investors including Purple Orange Ventures, Breakthrough Energy, Blue Horizon, Novo Holdings, Spero Ventures, Digitalis Ventures, GreenGen, Gaingels, Alexandria, and Green Generation Fund. The company operates in the food technology sector, specifically in the novel foods and early life nutrition categories.